Capex Updates, Expansion of Production Capacity, and New Product Launches

Out of this massive inventory, a substantial chunk of 2.97 lakh square feet, with a sale value of Rs. 1183.7 crore, found new owners in the private sector, further boosting

The stock has soared an astonishing 168.32 percent over the past year, rightfully earning its reputation as a multibagger stock. With a return on equity (ROE) standing tall at an impressive 43 per cent

Often referred to as the "man with the Midas touch," Kedia holds a remarkable 12.07 per cent stake in the stock, equivalent to 1,228,800 shares. His association with the company is a strong vote of confidence in its potential.

IBHFL has a proactive approach to Asset Liability Management (ALM) and plans ahead for situations involving clustered repayments, as was seen in Q2FY24. In such instances, where regulatory permissions allow, the company uses its balance sheet liquidity to pre-pay or buy back outstanding debt

In an unprecedented turn of events, the company proudly proclaims the acquisition of a colossal order, valued at Rs 21 crore, taxes included, destined for a domestic client. The clock ticks resolutely towards a promising deadline, with the commitment to fulfill this substantial order by the end of October 2023.

The stock gave multibagger returns of 250 per cent in just 1 year whereas BSE Sensex Index is up by 11.65 per cent.

SMS group chose to work with ABB on this project because of its proven expertise in providing reliable, high-performance powertrain solutions for the demanding applications found in steel mills.

Talking about the financials, the company is a small-cap company with a market cap of Rs 1,380 crore with a 3-year stock price CAGR of 82 per cent.

This approval, for its Enoxaparin product in pre-filled syringes, comes from the largest pharmaceutical market in the Gulf Cooperation Council (GCC) region. This market is projected to grow to USD 13.1 billion by 2031, with a 10-year CAGR of 5.4 per cent.